109
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Lichen Sclerosus of the Labial Mucosa: A Case Report and Literature Review

ORCID Icon, ORCID Icon & ORCID Icon
Pages 253-258 | Received 06 Nov 2023, Accepted 12 Jan 2024, Published online: 31 Jan 2024

References

  • Wallace HJ. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc. 1971;57(1):9–30.
  • Meffert JJ, Davis BM, Grimwood RE. Lichen sclerosus. J Am Acad Dermatol. 1995;32(3):393–416. doi:10.1016/0190-9622(95)90060-8
  • Friedrich EG, DiPaola GR, Hewitt J, Woodruff JD. New nomenclature for vulvar disease. J Cutan Pathol. 1976;3(3):159–161. doi:10.1111/j.1600-0560.1976.tb01105.x
  • Singh N, Etiology GP, Features C. Diagnosis of Vulvar Lichen Sclerosus: a Scoping Review. Obstet Gynecol Int. 2020;2020:7480754. doi:10.1155/2020/7480754
  • Kakko T, Salo T, Siponen MK. Oral lichen sclerosus: a systematic review of reported cases and two new cases. Int J Dermatol. 2018;57(5):521–528. doi:10.1111/ijd.13870
  • Vachiramon V, Suchonwanit P, Thadanipon K. Bilateral linear lichen planus pigmentosus associated with hepatitis C virus infection. Case Rep Dermatol. 2010;2(3):169–172. doi:10.1159/000320775
  • Miller RF. Lichen sclerosus et atrophicus with oral involvement: histopathologic study and dermabrasive treatment. AMA Arch Dermatol. 1957;76(1):43–55. doi:10.1001/archderm.1957.01550190047010
  • De Luca DA, Papara C, Vorobyev A, et al. Lichen sclerosus: the 2023 update. Front Med Lausanne. 2023;10:1106318. doi:10.3389/fmed.2023.1106318
  • Meani R, Howard A, Veysey E. Incidence of vulval squamous cell carcinoma in women with vulval lichen sclerosus in an Australian tertiary referral centre. Australas J Dermatol. 2019;60(1):76–77. doi:10.1111/ajd.12873
  • Burshtein A, Burshtein J, Rekhtman S. Extragenital lichen sclerosus: a comprehensive review of clinical features and treatment. Arch Dermatol Res. 2023;315(3):339–346. doi:10.1007/s00403-022-02397-1
  • Sergeant A, Vernall N, Mackintosh LJ, McHenry P, Leman JA. Squamous cell carcinoma arising in extragenital lichen sclerosus. Clin Exp Dermatol. 2009;34(7):e278–279. doi:10.1111/j.1365-2230.2008.03195.x
  • Sotillo Gago I, Martínez Sahuquillo A, Matilla A, García Pérez A. [Spinocellular epithelioma following scleroatrophic autoaneous licher]. Actas Dermosifiliogr. 1977;68(3–4):219–220. Spanish.
  • Marangon Júnior H, Souza PEA, Soares RV, Gomez RS, Pereira GHM, Horta MCR. Oral lichen sclerosus: a rare case report and review of the literature. Head Neck Pathol. 2017;11(2):212–218. doi:10.1007/s12105-016-0766-x
  • Attili VR, Attili SK. Lichen sclerosus of lips: a clinical and histopathologic study of 27 cases. Int J Dermatol. 2010;49(5):520–525. doi:10.1111/j.1365-4632.2010.04288.x
  • Mahasaksiri T, Kositkuljorn C, Anuntrangsee T, Suchonwanit P. Application of topical immunotherapy in the treatment of alopecia areata: a review and update. Drug Des Devel Ther. 2021;15:1285–1298. doi:10.2147/dddt.S297858
  • Rattanakaemakorn P, Suchonwanit P. Scalp pruritus: review of the pathogenesis, diagnosis, and management. Biomed Res Int. 2019;2019:1268430. doi:10.1155/2019/1268430
  • Lehner J, Agbo-Godeau S, Bertolus C. A retrospective study of 23 cases: are lichenoid lesions of the labial mucosa induced? Cureus. 2022;14(5):e25012. doi:10.7759/cureus.25012
  • Chanprapaph K, Pomsoong C, Tankunakorn J, Eden C, Suchonwanit P, Rutnin S. Comparative analyses of clinical features, histopathology, and CD123 immunohistochemistry of oral lupus erythematosus, lichen planus, and other lichenoid lesions. Dermatology. 2022;238(3):464–475. doi:10.1159/000517971
  • Idrees M, Kujan O, Shearston K, Farah CS. Oral lichen planus has a very low malignant transformation rate: a systematic review and meta-analysis using strict diagnostic and inclusion criteria. J Oral Pathol Med. 2021;50(3):287–298. doi:10.1111/jop.12996
  • Suchonwanit P, Kositkuljorn C, Pomsoong C. Alopecia areata: an autoimmune disease of multiple players. Immunotargets Ther. 2021;10:299–312. doi:10.2147/itt.S266409
  • Fistarol SK, Itin PH. Diagnosis and treatment of lichen sclerosus: an update. Am J Clin Dermatol. 2013;14(1):27–47. doi:10.1007/s40257-012-0006-4
  • Suchonwanit P, Kositkuljorn C, Mahasaksiri T, Leerunyakul K. A comparison of the efficacy and tolerability of three corticosteroid treatment regimens in patients with alopecia areata. J DermatolTreat. 2022;33(2):756–761. doi:10.1080/09546634.2020.1773384
  • Kreuter A, Kryvosheyeva Y, Terras S, et al. Association of autoimmune diseases with lichen sclerosus in 532 male and female patients. Acta Derm Venereol. 2013;93(2):238–241. doi:10.2340/00015555-1512
  • Bieber AK, Steuer AB, Melnick LE, Wong PW, Pomeranz MK. Autoimmune and dermatologic conditions associated with lichen sclerosus. J Am Acad Dermatol. 2021;85(1):228–229. doi:10.1016/j.jaad.2020.08.011
  • Azurdia RM, Luzzi GA, Byren I, et al. Lichen sclerosus in adult men: a study of HLA associations and susceptibility to autoimmune disease. Br J Dermatol. 1999;140(1):79–83. doi:10.1046/j.1365-2133.1999.02611.x
  • Marren P, Yell J, Charnock FM, Bunce M, Welsh K, Wojnarowska F. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol. 1995;132(2):197–203. doi:10.1111/j.1365-2133.1995.tb05013.x
  • Chanprapaph K, Sutharaphan T, Suchonwanit P. Scalp biophysical characteristics in males with androgenetic alopecia: a comparative study with healthy controls. Clin Interv Aging. 2021;16:781–787. doi:10.2147/cia.S310178
  • Paulis G, Berardesca E. Lichen sclerosus: the role of oxidative stress in the pathogenesis of the disease and its possible transformation into carcinoma. Res Rep Urol. 2019;11:223–232. doi:10.2147/rru.S205184
  • Suchonwanit P, Triyangkulsri K, Ploydaeng M, Leerunyakul K. Assessing biophysical and physiological profiles of scalp seborrheic dermatitis in the Thai population. Biomed Res Int. 2019;2019:5128376. doi:10.1155/2019/5128376
  • Skupsky H, Abuav R, High W, Pass C, Goldenberg G. Development of lichen sclerosus et atrophicus while receiving a therapeutic dose of imatinib mesylate for chronic myelogenous leukemia. J Cutan Pathol. 2009;37:877–880. doi:10.1111/j.1600-0560.2009.01398.x
  • Conteduca V, Medri M, Mazzoni L, De Giorgi U, Stanganelli I. Anogenital lichen sclerosus et atrophicus lesions in a case series of cancer patients on immunotherapy. Cancer Immunol Immunother. 2022;71(6):1545–1548. doi:10.1007/s00262-021-03094-0
  • Miraglia E, Soda G, Giustini S. Genital lichen sclerosus after nivolumab. Dermatol Online J. 2020;26:11.
  • Kirtschig G, Becker K, Günthert A, et al. Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus. J Eur Acad Dermatol Venereol. 2015;29(10):e1–43. doi:10.1111/jdv.13136
  • Robledo-Sierra J, Bäckman K, Öhman J, Jontell M. Oral lichen sclerosus: an overview and report of three cases. Int J Oral Maxillofac Surg. 2018;47(12):1550–1556. doi:10.1016/j.ijom.2018.04.006
  • Ravits HG, Welsh AL. Lichen sclerosus et atrophicus of the mouth. AMA Arch Dermatol. 1957;76(1):56–58. doi:10.1001/archderm.1957.01550190060011